Mercado de tratamiento del síndrome del intestino irritable: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00006814
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 180
Buy Now

El mercado de tratamiento del síndrome del intestino irritable (SII) se valoró en 2.153,89 millones de dólares en 2020 y se prevé que alcance los 4.600,30 millones de dólares en 2028; se espera que crezca a una tasa compuesta anual del 10,1% de 2021 a 2028.

Los factores principales, como la creciente prevalencia de las enfermedades del síndrome del intestino irritable y el aumento de la investigación y la investigación. Las actividades de desarrollo impulsan el crecimiento del mercado. Sin embargo, el número limitado de disponibilidad de productos y la ineficiencia del tratamiento frenan el crecimiento del mercado. El SII es una afección crónica común que afecta el órgano abdominal, el intestino grueso. También se le conoce como colon espástico, colitis mucosa, colon irritable y colitis espástica. La afección es muy diferente a la enfermedad inflamatoria intestinal. Muestra síntomas como calambres, dolor abdominal, hinchazón, gases y diarrea o estreñimiento, o ambos a la vez. Si los síntomas son leves, se pueden controlar cambiando el estrés, el estilo de vida y la dieta. Por otro lado, los síntomas graves se tratan con medicación y asesoramiento.

En APAC, se han implementado muchas medidas para contener la propagación del nuevo coronavirus que causa el COVID-19. Las medidas han interrumpido las operaciones de muchas empresas en diversas industrias, incluida la industria de la salud. La cuarentena del personal, las fallas en la cadena de suministro y las reducciones en la demanda han generado serias complicaciones para las empresas. Además, ha habido una caída significativa en la atención hospitalaria y ambulatoria en las cadenas hospitalarias privadas. Para aliviar los sistemas de salud, muchas clínicas están posponiendo citas no críticas. Este escenario está obstaculizando el crecimiento del tratamiento del síndrome del intestino irritable (SII).

regiones lucrativas para el mercado del tratamiento del síndrome del intestino irritable (SII)


Perspectivas del mercado

Prevalencia creciente del síndrome del intestino irritable y afecciones asociadas

El síndrome del intestino irritable es una afección gastrointestinal crónica que se observa principalmente y que es causada debido a alteraciones en los hábitos intestinales y dolor abdominal. La enfermedad también se conoce como colon espástico, colon irritable, colitis mucosa y colitis espástica. El síndrome del intestino irritable muestra síntomas como dolor abdominal, estreñimiento, diarrea y calambres. Los sistemas de salud de todas las regiones están presenciando un crecimiento considerable en la incidencia del síndrome del intestino irritable. Un dato publicado por la Fundación Internacional para los Trastornos Gastrointestinales afirma que entre todos los pacientes con SII, alrededor del 40% de los pacientes tiene SII leve, alrededor del 35% tiene SII moderado y se estima que el 25% sufre SII grave. Mucha gente no reconoce los síntomas del SII.

Ciertos factores como alergias alimentarias, etapas de gastroenteritis en desarrollo, movimientos esporádicos del colon, composición anormal de la serotonina en el colon y enfermedad celíaca leve se encuentran entre los factores de riesgo que pueden causar el SII. Se prevé que estos factores aceleren la tasa de prevalencia del SII en todo el mundo. Por ejemplo, según un estudio publicado en NCBI en 2018, se estima que el SII afecta entre el 10 % y el 16 % de la población de EE. UU. cada año. Es probable que una prevalencia tan asombrosa del SII impulse el mercado de tratamiento del síndrome del intestino irritable (SII) durante el período previsto.

Información basada en el tipo

Según el tipo, el mercado de tratamiento del síndrome del intestino irritable (SII) se segmenta en SII mixto (SII-M) , SII con diarrea (SII-D) y SII con estreñimiento (SII-E). En 2020, el segmento mixto de IBS (IBS-M) tuvo la mayor participación del mercado. Además, se prevé que el mismo segmento registre la CAGR más alta durante el período de pronóstico. Se prevé que la creciente prevalencia del SII entre mujeres y hombres impulse la demanda de medicamentos que puedan tratar los síntomas combinados de estreñimiento y diarrea. La prevalencia del SII es mayor en la población de edad avanzada. Por lo tanto, es probable que la demanda de medicamentos para tratar el SII mixto crezca significativamente durante el período de pronóstico.

Mercado de tratamiento del síndrome del intestino irritable (SII), por tipo:

Mercado de tratamiento del síndrome del intestino irritable (SII), por tipo: 2020 y 2028

Información basada en productos

Según el producto, el mercado de tratamiento del síndrome del intestino irritable (SII) se segmenta en rifaximina, eluxadolina y lubiprostona. , linaclotida y otros. El segmento de linaclotida tuvo la mayor participación del mercado en 2020. Además, se estima que el mismo segmento registrará la CAGR más alta del mercado durante el período de pronóstico. El crecimiento del mercado para el segmento se atribuye a factores como la creciente fabricación de la versión genérica de linaclotida y la creciente consolidación del mercado para el desarrollo y comercialización de linaclotida para tratar el SII.

Información basada en el canal de distribución

Según el canal de distribución, el mercado de tratamiento del síndrome del intestino irritable (SII) se segmenta en farmacias de hospitales, farmacias minoristas y farmacias en línea. En 2020, el segmento de farmacias hospitalarias tuvo la mayor participación del mercado. Sin embargo, se espera que el segmento de farmacias y farmacias minoristas registre la CAGR más alta durante el período de pronóstico.

Perspectivas estratégicas

Las empresas que operan en el mercado de tratamiento del síndrome del intestino irritable (SII) adoptan la estrategia de innovación de productos para satisfacer las cambiantes demandas de los clientes en todo el mundo, lo que también les permite mantener su marca en el mercado global.

Mercado del tratamiento del síndrome del intestino irritable (SII): por tipo

  • SII con diarrea (SII-D)
  • SII con estreñimiento (SII-E)
  • SII mixto (SII-M)< /li>

Mercado del tratamiento del síndrome del intestino irritable (SII): por Producto

  • Rifaximina
  • Eluxadolina
  • Linaclotida
  • Lubiprostona
  • Otros
  • < /ul>

    Mercado del tratamiento del síndrome del intestino irritable (SII): por canal de distribución

    • Farmacias hospitalarias
    • Farmacias y farmacias minoristas
    • Farmacias online

    Síndrome del intestino irritable (IBS) Mercado de tratamiento: por Geografía

    • América del Norte
      • Estados Unidos
      • Canadá
      • México
    • < li>Europa
      • Francia
      • Alemania
      • Italia
      • Reino Unido
      • España
      • Resto de Europa
    • Asia Pacífico (APAC)
      • China
      • India
      • Corea del Sur
      • Japón
      • Australia
      • Resto de APAC
    • Oriente Medio y África (MEA)
      • Sudáfrica
      • Arabia Saudita
      • EAU
      • Resto de MEA
    • América del Sur y Central (SCAM )
      • Brasil
      • Argentina
      • Resto de ESTAFA

    Perfiles de Empresas

    • Ironwood Pharmaceuticals, Inc.
    • AbbVie.
    • Sebela Pharmaceuticals, Inc.
    • Takeda Pharmaceutical Company Limited
    • Alfasigma SpA
    • Astellas Pharma Inc.
    • AstraZeneca
    • Synthetic Biologics, Inc.
    • Bausch + Lomb Incorporated
    • < li>Lannett Company Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is irritable bowel syndrome (IBS) treatment?

Irritable bowel syndrome (IBS) is a common disorder that affects the abdominal organ, large intestine. It is also known as spastic colon, mucous colitis, irritable colon, and spastic colitis. The condition is much different than inflammatory bowel disease. However, it is a chronic condition which a person must manage for a longer period. It shows symptoms such as cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both at the same. These symptoms can be managed by changing stress, lifestyle, and diet. And the more severe symptoms are treated with medication and counseling.

What are the driving factors for the irritable bowel syndrome (IBS) treatment market across the globe?

The factors that are driving growth of the market are increasing prevalence of irritable bowel syndrome diseases and increasing research & development activities.

Who are the major players in the irritable bowel syndrome (IBS) treatment market?

The irritable bowel syndrome (IBS) treatment market majorly consists of the players such as Ironwood Pharmaceuticals, Inc., AbbVie., Sebela Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Alfasigma S.p.A., Astellas Pharma Inc., AstraZeneca, Synthetic Biologics, Inc., Bausch + Lomb Incorporated and Lannett Company Inc amongst others.

The List of Companies - Irritable Bowel Syndrome (IBS) Treatment Market

  1. Ironwood Pharmaceuticals, Inc.
  2. AbbVie.
  3. Sebela Pharmaceuticals, Inc.
  4. Takeda Pharmaceutical Company Limited
  5. Alfasigma S.p.A.
  6. Astellas Pharma Inc.
  7. AstraZeneca
  8. Synthetic Biologics, Inc.
  9. Bausch + Lomb Incorporated
  10. Lannett Company Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports